Nick Wilson, Frederieke Sanne van der Deen, Richard Edwards, George Thomson, Anaru Waa, Tony Blakely
Just published results from the NZ Health Survey indicate ongoing declines in smoking for Māori and for European New Zealanders. In this blog we comment on the possible reasons for these trends and describe recent work on how progress could be accelerated.
Prof Nick Wilson, Dr Nhung Nghiem, Dr Cristina Cleghorn, Dr Frederieke Sanne van der Deen, Prof Tony Blakely
We have just published a journal article on the cost-effectiveness of NZ’s Quitline service (including its associated promotion in the mass media). The study found that this intervention package is likely to be an effective means to generate health gain, address health inequalities and save costs for the NZ health system. But in this blog we also compare the New Zealand Quitline intervention with other tobacco interventions using our just launched BODE3 Interactive League Table, and find that whilst the Quitline is a good thing to do, much more health gain is possible through other tobacco control interventions.
Frederieke Sanne van der Deen, Prof Nick Wilson, Dr Christine Cleghorn, Dr Linda Cobiac, Dr Giorgi Kvizhinadze, Dr Nhung Nghiem, Prof Tony Blakely
We have eight more years to go until 2025 – the year of the NZ Government’s Smokefree goal. NZ is not on track to achieve this goal, especially not for Māori. In this blog we discuss the findings of our just published study in Tobacco Control, where we have estimated the future impacts of a range of proposed novel and substantive strategies that may accelerate the reduction in smoking prevalence (ie, ‘tobacco endgame strategies’). We find that some endgame strategies could achieve NZ’s Smokefree goal, deliver large health gains and cost-savings, and could largely reduce the ethnic gap in tobacco-related health inequalities.
Prof Janet Hoek, Mei-Ling Blank, Prof Nick Wilson, Lindsay Robertson, Dr Louise Marsh
Do the New Zealand (NZ) Government’s proposed changes to liberalise the e-cigarette market set out a robust process for helping people who smoke to switch to e-cigarettes? In this blog, we discuss the proposed regulatory changes and explain some of the complex practices smokers must adopt when commencing vaping. We suggest limiting supply of nicotine e-cigarettes to specialist vape stores and pharmacies, to ensure people wishing to quit smoking can obtain expert advice and thus maximise their chances of quitting. We also argue that, at the same time as liberalising access to nicotine e-cigarettes, the Government should restrict access to tobacco, which remains available at thousands of retail outlets throughout NZ.
Professor Janet Hoek, Professor Karine Gallopel-Morvan, Professor Richard Edwards, Professor Tony Blakely
New Zealand’s Smokefree 2025 goal is now less than ten years away but we are unlikely to achieve this world-leading goal unless the Government introduces innovative new policies that reduce smoking prevalence (1). Existing measures have tackled different facets of tobacco marketing, with plain packaging reducing a potent form of tobacco marketing and excise tax increases making smoking less affordable. However, tobacco products themselves have received less attention. In this blog we outline findings from recent studies examining roll-your-own tobacco use and explore potential policy implications.
Roll-your-own tobacco (RYO) has increased in popularity, largely due to its cost advantages, which have persisted despite efforts to reduce differences in the excise tax on RYO tobacco and tailor made (TM) cigarettes (2). Many New Zealand smokers now use loose tobacco to make RYO cigarettes, which are typically around half to two-thirds the size of TM cigarettes (3,4). RYO use is higher among younger demographics, particularly young adults aged 20-24, where more than 60% smoke RYO, either exclusively (42%) or in conjunction with TM cigarettes (20%) (3). Among 25-45 year olds, RYO use (exclusive and with TM cigarettes) is 57%. RYO use is higher among Māori and NZ Europeans than among Pacific peoples (see figure below); people experiencing greater deprivation are also more likely to use RYO tobacco than smokers who experience less deprivation (3). Furthermore, New Zealand RYO smokers are also more likely than TM cigarette smokers to have co-morbidities such as mental health illnesses, illicit drug addictions, and risky drinking behaviours (5).